Richard Musa
Madison,NJ
Summary
Engaging leader with 25+ years of broad cross-functional experience in internal and external pharmaceutical manufacturing. Strong technical and business training and experience. Proven track record of managing successful business transitions and operational improvement initiatives.
Overview
29
29
years of professional experience
Work History
Director & Head Supply Chain
Cipla Therapeutics
Warren, USA
02.2022 - Current
- End-to-end manufacturing and supply chain lead, and key member of cross-functional leadership team for branded pharmaceutical division of Cipla
- Accountable for all aspects of manufacturing and supply of a commercially distributed specialty product, supply planning for launch of a pipeline of 8 internally developed products, and supply chain and operations due diligence for series of business development assets evaluated for purchase offers
- Led cross-functional Virtual Manufacturing Team to ensure timely and compliant planning and execution of all operations, supply, quality, and regulatory activities for a US commercially marketed sterile finished product
- Reduced inventory scrap liability associated by negotiating a ~25% reduction of finished good contractual take-or-pay obligations and facilitating activities to extend API and finished good shelf life by 2-3 years
- Facilitated supply and operations activities required to receive marketing authorization and import license to launch US commercial product in India, and file same product in South Africa for marketing authorization
- Performed operations and supply due diligence activities for 13 asset acquisition targets, and reverse due diligence activities for 1 asset sale
Director External Supply
Zoetis
Florham Park & Parsippany, USA
05.2013 - 02.2022
- Led team of up to 12 Operations/Category and Supply Chain Managers, managing a portfolio of up to 46 US-based third-party finished good suppliers, supplying up to 330+ SKUs globally (50+countries), representing up to $110 Million in COGS, and up to $360 Million in annual revenue
- Accountable for adherence to financial, customer service, quality, and risk management performance metrics, negotiation of service and supply agreements, third-party drug product sourcing for new or transferred products, and operations representation on transfer and due diligence teams
- Implemented routines and proactively addressed supply issues to increase year-on-year customer service levels and reduction in quality high risk suppliers for five consecutive years
- Drove cost savings initiatives resulting in 13% (2017) and 6% (2018) budget-to-budget COGS reductions, and actual-to-budget savings of 3% (2015), 5% (2016) & 4% (2017)
- Led US External Supply Team through Zoetis separation process and de-centralization of supply chain functions to successfully implement a streamlined customer focused external supply team
Sr. Manager External Supply
Pfizer
Peapack, USA
01.2011 - 05.2013
- Led cross-functional Virtual Site Operating Teams (VSOT) to supply products from a portfolio up to 22 US third-party suppliers, representing ~$50 Million in annual spend
- Accountable for adherence to customer service, quality, and risk management performance metrics, negotiation of service and supply agreements, third-party drug product sourcing for new or transferred products, operations and supply chain representation on transfer and due diligence teams
- Initiated and led independent biological-product focused VSOT for large, low-performing supplier to exceed % In-Stock metric by 24% of 2012 target
- Implemented routines and proactively addressed potential supply issues to achieve 100% in-stock, 100% first-time-right, and 100% risk-management, quality, and APR commitment adherence for all suppliers in 2012
Associate Director Engineering & Validation
Wyeth/Pfizer
Pearl River, USA
10.2006 - 01.2011
- Managed team of 12 Managers/Engineers (+contract resources), responsible for engineering, qualification, validation, and verification activities to support manufacturing operations to supply a vaccine generating annual revenues of more than $2 Billion
- Managed budgeting and project management associated with up to $34 Million of capital funding
- Led validation team to perform aseptic media simulation studies to allow implementation of tandem filling campaigns, increasing syringe filling line capacity by 40%
- Led qualification and validation activities required for start-up of commercial vial-filling operations, ensuring adherence to compliance, budget and schedule requirements
- Ensured timely filing of 'next generation' product as site drug product representative on cross-site validation team responsible for validation harmonization and completion of validation studies and associated filing documents
- Implemented process to integrate responsibility for equipment qualification (IQ, OQ, PQ) activities and expertise into existing Project Engineering roles
- Led team to utilize Lean Six Sigma and Operational Excellence concepts and tools to streamline equipment life cycle through implementation of a Risk Based, Quality by Design, ASTM E2500 Verification approach
Associate Director Biotech Manufacturing Operations
Wyeth
Pearl River, USA
08.2002 - 10.2006
- Led a three-shift aseptic filling operation staffed by 14 Managers/Supervisors and 98 bargaining unit operators, and a fermentation and purification operation staffed by 12 Managers/Supervisors and 32 bargaining unit operators responsible for fermentation, purification, and associated support operations
- Accountable for supply of a conjugated pneumococcal vaccine with annual sales revenue of more than $2 Billion
- Maintained workforce morale and facilitated technical and operational solutions during workforce downsizing and transition from vial filling to a syringe filling operation, allowing for an un-interrupted supply of vaccine to the market
- Fostered a culture QA collaboration, sponsored enhance batch record usability initiative, and implemented communication tools to reduce release cycle time by 75% and batch record errors by 80% (Q2 2005 versus 2003)
- Implemented critical utility usage management and alternate operations shifts to offset peak utility usage activities, allowing for a 100% increase in drug substance production capacity to meet commercial and clinical demands
Manager, Material Supply
Wyeth
09.2001 - 08.2002
- Managed a team of 9 supervisors/clerical assistants and 41 bargaining unit truck/trailer drivers and warehouse workers responsible for receipt, handling, tracking, and delivery of 250 pallets and 335 small packages per day, and storage, tracking and maintenance of 7,500 pallets of production material to support pharmaceutical, vaccines, and consumer health products manufacturing and research organizations
- Developed and implemented operational procedures to meet requirements of Consent Decree commitments to ensure an efficient, compliant material supply operation
Manager, Technical Operations
Wyeth
11.2000 - 09.2001
- Led a technical support team of 7 project engineers & managers responsible for providing technical/logistical support and equipment life cycle management to a 24 hour - 7 day consumer health product manufacturing operation
- Developed cost/capacity model recommendations for labor/equipment resourcing, expense/capital budgeting, and product outsourcing recommendations
- Developed a 5-year, $200 Million dollar capital budget plan to maintain the manufacturing operation at the required level of capacity, efficiency, and regulatory compliance
- Managed a $10.6 Million capacity expansion to increase production capacity from 6.4 to 9.9 Billion tablets annually
Production Engineer, Consumer Health Products
Wyeth
09.1999 - 11.2000
Research Engineer, Bioprocess Development
Lab Support Inc.
01.1996 - 09.1999
Education
MBA - Finance
NYU Stern School of Business
05.2001
MS - Chemical Engineering
Manhattan College
02.1994
BS - Chemical Engineering
Manhattan College
05.1991
Skills
- External Supply
- Agreement Negotiation
- Animal & Human Health
- Manufacturing Start-Up
- Bioprocess Operations
- Performance Management
- Validation & Qualification
- Risk-Based Verification
- Transition Management
- Inspection Readiness
- Capital Planning
- Aseptic Manufacturing
Websites
Timeline
Director & Head Supply Chain
Cipla Therapeutics
02.2022 - Current
Director External Supply
Zoetis
05.2013 - 02.2022
Sr. Manager External Supply
Pfizer
01.2011 - 05.2013
Associate Director Engineering & Validation
Wyeth/Pfizer
10.2006 - 01.2011
Associate Director Biotech Manufacturing Operations
Wyeth
08.2002 - 10.2006
Manager, Material Supply
Wyeth
09.2001 - 08.2002
Manager, Technical Operations
Wyeth
11.2000 - 09.2001
Production Engineer, Consumer Health Products
Wyeth
09.1999 - 11.2000
Research Engineer, Bioprocess Development
Lab Support Inc.
01.1996 - 09.1999
MBA - Finance
NYU Stern School of Business
MS - Chemical Engineering
Manhattan College
BS - Chemical Engineering
Manhattan College
Similar Profiles
Anthony J. Varano, Jr.Anthony J. Varano, Jr.
Co-Founder, CEO & Investor at Cervello Therapeutics & Resero TherapeuticsCo-Founder, CEO & Investor at Cervello Therapeutics & Resero Therapeutics
AMIT AMBESANGEAMIT AMBESANGE
Manager Drug safety at CiplaManager Drug safety at Cipla
Camelia DasCamelia Das
Senior Regional Customer Marketing Executive at Cipla Health Ltd.Senior Regional Customer Marketing Executive at Cipla Health Ltd.
BARBARA MORRISONBARBARA MORRISON
Communications Manager at AbbVieCommunications Manager at AbbVie
Morgan WillisMorgan Willis
Private Field Hockey Lessons at Self-employedPrivate Field Hockey Lessons at Self-employed